(KP_MAT) Number of people who inject drugs (PWID) on medication-assisted therapy (MAT) for at least 6 months
When proper and sufficient dosage is administered, medication-assisted therapy (MAT) is highly effective in reducing opioid use and the injecting behaviors that put opioid-dependent people at risk for HIV. In addition, MAT can help improve retention for those who are on ART. Therefore, all people who are dependent on opioids should be offered and have access to this service. The implementation of MAT programs should facilitate and enhance access to HIV-specific services for PWID including HIV testing services, linkages to ARV treatment programs, PMTCT for female PWID, and a range of other prevention and harm reduction services.
Implementing partners providing MAT referrals-only should not use this indicator unless it the services being provided meet the KP_MAT_TA requirement outlined in the PEPFAR-support definitions below. Please refer to the “KP_PREV” indicator to see if the services provided meet reporting criteria for that indicator as well.
Number of people who inject drugs (PWID) on medication-assisted therapy (MAT) for at least 6 months within the reporting period
How to calculate annual total:
N/A. Data is reported only once annually at Q4.
How to collect:
This indicator provides information on the total number of individuals who have been on medication-assisted therapy (e.g., methadone, buprenorphine, or buprenorphine/naloxone to treat drug dependency) for at least six months within the reporting period. Consequently, data for this indicator can be generated by counting the number of individuals who are currently receiving MAT or received at least 6 months of MAT in the reporting period in accordance with the nationally approved treatment protocol (or WHO/UNAIDS standards) at the end of the reporting period.
Count all individuals who have completed at least 6 months of MAT even if they drop-out, die, or are otherwise lost to follow-up, as long as they completed the minimum of 6 months MAT within the reporting period. Do not count individuals who initiate treatment too late in the reporting period to be able to reach a minimum of 6 months by the time of reporting.
How to review for data quality
This indicator makes use of program data as part of an on-going cohort. The MAT register and/or patient-level data can be used to determine the number of people starting MAT in the defined period, as a cohort, and the number of those who are still in treatment 6 months and who were on MAT for at least six months during the reporting period.
Data should be reviewed regularly for the purposes of program management, to monitor progress towards achieving targets, and to identify and correct any data quality issues.
This indicator provides information on the total number of individuals who have been on treatment for at least 6 months within the reporting period.
Indicator changes (MER 2.0 v2.2 to v2.3):
PEPFAR Support definition:
Standard definition of DSD and TA-SDI used: